Rising Pharma Holdings, Inc. is recalling 4,260 bottles of Lansoprazole (15 mg) delayed-release capsules manufactured by Natco Pharma Limited. The recall was initiated due to several manufacturing defects, including improperly sealed bottles, capsules with holes, bubbles on the capsule seals, and some bottles missing required expiration and lot coding information. These defects were discovered during a quality review and affect the 14-count bottles of the medication.
Inadequate bottle seals and holes in capsules can expose the medication to air and moisture, which may cause the drug to break down and become less effective. Additionally, compromised packaging could lead to potential contamination, posing a risk to patients relying on the medication for heartburn treatment.
You have 2 options:
Manufactured by Natco Pharma Limited; Distributed by Rising Pharma Holdings, Inc.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.